CU Anschutz Secures FDA IND for CAR T-Cell Therapy
AURORA, Colo., April 2, 2026 The University of Colorado Anschutz Medical Campus Gates Institute announced it has received U.S....
FDA IND Clearance
Advertisement
Siren Biotech FDA IND Clearance for Glioma Trial
SAN FRANCISCO, CA, March 23, 2026 Siren Biotechnology has announced that the U.S. Food and Drug Administration (FDA) has...
FDA Clears First Nerve-Specific Imaging Agent for Surgery
PORTLAND, Ore., Jan. 31, 2026 — Trace Biosciences announced that the U.S. Food and Drug Administration (FDA) has granted...
FDA Clears Scancell IND for Phase 3 iSCIB1+ Melanoma Trial
Cambridge, United Kingdom, January 26, 2026 — Scancell Holdings plc announced on January 26, 2026, that the U.S. Food...
FDA Clears MRM Health’s Phase 2b Microbiome Trial in UC
GHENT, Belgium | January 9, 2026 — MRM Health announced that the U.S. Food and Drug Administration (FDA) has...
Advertisements
GenEditBio Wins FDA IND Clearance for GEB-101 Therapy
HONG KONG | January 5, 2026 — GenEditBio has received U.S. FDA clearance of its Investigational New Drug (IND)...
FDA Clears Ascletis ASC30 Phase II Diabetes Study
HONG KONG, Jan. 5, 2026 — Ascletis Pharma Inc. announced that it has received Investigational New Drug (IND) clearance...
FDA Clears Allogeneic CAR-T MT027 for Phase II Glioblastoma
December 21, 2025 | Beijing, China — T-MAXIMUM Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has...
FDA Clears Tonix IND for TNX-102 SL in Major Depression
Chatham, New Jersey, November 24, 2025 — Tonix Pharmaceuticals announced that the U.S. Food & Drug Administration has cleared...
FDA Clears Jupiter Neurosciences’ JOTROL™ for Phase 2a Parkinson’s Trial
JUPITER, Florida, November 5, 2025 — Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage biopharmaceutical company, announced that the U.S....
Advertisement
